A detailed history of Stonnington Group, LLC transactions in Insulet Corp stock. As of the latest transaction made, Stonnington Group, LLC holds 1,000 shares of PODD stock, worth $260,120. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,000
Holding current value
$260,120
% of portfolio
0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 14, 2023

BUY
$276.36 - $326.03 $276,360 - $326,030
1,000 New
1,000 $318,000
Q3 2021

Oct 12, 2021

SELL
$260.36 - $307.27 $206,986 - $244,279
-795 Closed
0 $0
Q2 2021

Jul 09, 2021

BUY
$225.52 - $304.06 $179,288 - $241,727
795 New
795 $225,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.1B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Stonnington Group, LLC Portfolio

Follow Stonnington Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonnington Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonnington Group, LLC with notifications on news.